Chengzheng Wang
127 Dongming Road
Zhengzhou, 450008, China
Zhengzhou, 450008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
(Neo)adjuvant therapy patterns and outcomes in patients with HR+/HER2+ early breast cancer: a real-world study using the national cancer information database in China.
Journal: Therapeutic advances in medical oncology
Published: October 17, 2025
Inetetamab plus camrelizumab and utidelone for pretreated HER2-positive advanced breast cancer: a prospective, single-arm, phase 2 study.
Journal: BMC medicine
Published: October 15, 2025
Utidelone Plus Bevacizumab for ERBB2-Negative Metastatic Breast Cancer and Active Brain Metastases: The U-BOMB Phase 2 Nonrandomized Clinical Trial.
Journal: JAMA oncology
Published: June 26, 2025
Application of Neoadjuvant Docetaxel plus Cisplatin in Early-Stage Triple-Negative Breast Cancer (HELEN-001): Results from a Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 24, 2025
A comparative study of mitoxantrone hydrochloride injection and technetium-99 m for tracing axillary sentinel nodes in patients with breast cancer.
Journal: BMC cancer
Published: March 06, 2024
Assessment of the impact of residual tumors at different sites post-neoadjuvant chemotherapy on prognosis in breast cancer patients and development of a disease-free survival prediction model.
Journal: Therapeutic advances in medical oncology
Published: December 17, 2023
Targeted axillary dissection after neoadjuvant chemotherapy for highly selective patients with initial cN1 breast cancer: A single-center prospective trial.
Journal: Chinese medical journal
Published: November 20, 2023
The Impact of Sentinel Lymph Node Biopsy on Female Patients With T3-4c Breast Cancer and 1-2 Positive Lymph Nodes: A Population-Based Cohort Study.
Journal: Clinical breast cancer
Published: October 21, 2023
A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: July 16, 2023
Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial.
Journal: Nature communications
Published: March 11, 2023
Effect of the HER-2/CEP17 ratio in IHC 2+/FISH-amplified breast cancer on pathological complete response to neoadjuvant pertuzumab and trastuzumab treatment-a retrospective cohort study.
Journal: Gland surgery
Published: September 20, 2022
Last Updated: 09/26/2026